AS-100283

N/A

Report date: 2025/05/15 15:19:52
NME

Base Information

Drug NameAS-100283
Drug Alias NameAS-100283AS283
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium/Calmodulin dependent protein kinase II inhibitors
TargetsCalcium/Calmodulin dependent protein kinase II
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAllosteros Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAllosteros Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A